dactinomycin and Cardiovascular Stroke

dactinomycin has been researched along with Cardiovascular Stroke in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (42.86)	18.7374
1990's	1 (14.29)	18.2507
2000's	3 (42.86)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barancík, M; Schaper, W; Strniskova, M; Strohm, C; Ullmann, C; von Bruehl, M; Zimmermann, R	1
Bett, JH; Buszman, P; Coleman, L; de Feyter, P; den Heijer, P; Glogar, HD; Grube, E; Johnson, R; Marco, J; Miquel, K; Ormiston, JA; Pitney, M; Polonski, L; Schömig, A; Serruys, PW; Sianos, G; Sousa, JE; Suttorp, MJ; Thuesen, L; Veldhof, S; Virmani, R; Whitbourn, R; Wilkins, GT; Zeiher, AM	1
Koltai, M; Leprán, I; Szekeres, L	1
Aksehirli, TO; Gaudette, GR; Krukenkamp, IB; Leavens, JE; Matsuyama, N; McKinnon, D	1
Downey, JM; Liu, GS; Stanley, AW; Striplin, S; Swafford, A; Thornton, J; Van Winkle, DM	1
Barnard, CN	1
Dong, E; Griepp, RB; Morrell, RM; Phillips, RC; Shumway, NE; Stinson, EB	1

Trials

1 trial(s) available for dactinomycin and Cardiovascular Stroke

Article	Year
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. Journal of the American College of Cardiology, 2004, Oct-06, Volume: 44, Issue:7 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Dactinomycin; Death, Sudden, Cardiac; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prospective Studies; Selection Bias; Single-Blind Method; Stents; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional	2004

Article

Year

Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.

Journal of the American College of Cardiology, 2004, Oct-06, Volume: 44, Issue:7

Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Dactinomycin; Death, Sudden, Cardiac; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prospective Studies; Selection Bias; Single-Blind Method; Stents; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional

2004

Other Studies

6 other study(ies) available for dactinomycin and Cardiovascular Stroke

Article	Year
Transcription inhibitor actinomycin-D abolishes the cardioprotective effect of ischemic reconditioning. Cardiovascular research, 2002, Aug-15, Volume: 55, Issue:3 Topics: Activating Transcription Factor 2; Analysis of Variance; Animals; Butadienes; Cyclic AMP Response Element-Binding Protein; Dactinomycin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; ets-Domain Protein Elk-1; Immunoblotting; Ischemic Preconditioning, Myocardial; Male; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocardium; Nitriles; Nucleic Acid Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; RNA, Messenger; Swine; Transcription Factors	2002
Effect of actinomycin D and cycloheximide on experimental myocardial infarction in rats. European journal of pharmacology, 1982, Jan-22, Volume: 77, Issue:2-3 Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Cycloheximide; Dactinomycin; Dexamethasone; Drug Interactions; Male; Myocardial Infarction; Rats; Rats, Inbred Strains	1982
Ischemic but not pharmacological preconditioning requires protein synthesis. Circulation, 2000, Nov-07, Volume: 102, Issue:19 Suppl 3 Topics: Action Potentials; Animals; Blood Flow Velocity; Blood Pressure; Coronary Vessels; Cycloheximide; Dactinomycin; Heart; Heart Function Tests; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardium; Organ Size; Pinacidil; Potassium Channels; Protein Biosynthesis; Protein Synthesis Inhibitors; Rabbits; Reperfusion Injury	2000
Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. The American journal of physiology, 1990, Volume: 259, Issue:6 Pt 2 Topics: Animals; Coronary Disease; Cycloheximide; Dactinomycin; Female; Heart; Male; Muscle Proteins; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Rabbits	1990
The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1967, Dec-30, Volume: 41, Issue:48 Topics: Azathioprine; Cobalt Isotopes; Dactinomycin; Heart Transplantation; Humans; Hydrocortisone; Male; Methods; Middle Aged; Myocardial Infarction; Postoperative Care; Prednisone; Surgical Wound Infection; Transplantation Immunology; Transplantation, Homologous	1967
Use of antithymocyte globulin in human heart transplantation. Circulation, 1972, Volume: 45, Issue:5 Suppl 1 Topics: Animals; Antilymphocyte Serum; Arteriosclerosis; Cardiomyopathies; Dactinomycin; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Horses; Humans; Immunosuppression Therapy; Lymphocytes; Male; Methylprednisolone; Middle Aged; Myocardial Infarction; Prednisone; Thymus Gland; Transplantation Immunology; Transplantation, Homologous	1972